Biomea Fusion Inc (BMEA)
8.84
-0.20
(-2.21%)
USD |
NASDAQ |
Nov 04, 16:00
8.84
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Total Assets (Quarterly): 110.42M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 110.42M |
June 30, 2024 | 136.16M |
March 31, 2024 | 168.49M |
December 31, 2023 | 199.93M |
September 30, 2023 | 225.09M |
June 30, 2023 | 248.67M |
March 31, 2023 | 112.64M |
December 31, 2022 | 129.31M |
Date | Value |
---|---|
September 30, 2022 | 145.05M |
June 30, 2022 | 161.74M |
March 31, 2022 | 174.86M |
December 31, 2021 | 185.70M |
September 30, 2021 | 199.40M |
June 30, 2021 | 209.53M |
March 31, 2021 | 59.88M |
December 31, 2020 | 62.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
59.88M
Minimum
Mar 2021
248.67M
Maximum
Jun 2023
158.09M
Average
165.12M
Median
Total Assets (Quarterly) Benchmarks
Clearside Biomedical Inc | 33.93M |
Crinetics Pharmaceuticals Inc | 935.54M |
NovaBay Pharmaceuticals Inc | 3.925M |
Palatin Technologies Inc | 10.74M |
iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 34.45M |
Shareholders Equity (Quarterly) | 75.97M |